State of Wisconsin Investment Board’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.27M | Buy |
158,505
+69,428
| +78% | +$2.07M | 0.01% | 964 |
|
|
2025
Q4 | $2.66M | Sell |
89,077
-76,183
| -46% | -$2.49M | 0.01% | 1298 |
|
|
2025
Q3 | $5.97M | Buy |
165,260
+8,941
| +6% | +$295K | 0.01% | 885 |
|
|
2025
Q2 | $5.63M | Sell |
156,319
-22,987
| -13% | -$856K | 0.01% | 889 |
|
|
2025
Q1 | $7.07M | Sell |
179,306
-15,858
| -8% | -$534K | 0.02% | 786 |
|
|
2024
Q4 | $5.87M | Buy |
195,164
+2,189
| +1% | +$62.8K | 0.02% | 878 |
|
|
2024
Q3 | $4.51M | Sell |
192,975
-41,594
| -18% | -$908K | 0.01% | 999 |
|
|
2024
Q2 | $4.17M | Buy |
234,569
+10,345
| +5% | +$165K | 0.01% | 1005 |
|
|
2024
Q1 | $3.41M | Buy |
224,224
+68,987
| +44% | +$1.1M | 0.01% | 1094 |
|
|
2023
Q4 | $2.65M | Sell |
155,237
-46,554
| -23% | -$541K | 0.01% | 1167 |
|
|
2023
Q3 | $1.69M | Buy |
201,791
+58,602
| +41% | +$817K | 0.01% | 1292 |
|
|
2023
Q2 | $3.56M | Buy |
143,189
+15,796
| +12% | +$408K | 0.01% | 1123 |
|
|
2023
Q1 | $1.92M | Sell |
127,393
-11,017
| -8% | -$167K | 0.01% | 1318 |
|
|
2022
Q4 | $1.64M | Sell |
138,410
-105,464
| -43% | -$765K | 0.01% | 1367 |
|
|
2022
Q3 | $1.44M | Sell |
243,874
-40,684
| -14% | -$267K | ﹤0.01% | 1427 |
|
|
2022
Q2 | $1.21M | Buy |
284,558
+64,858
| +30% | +$405K | ﹤0.01% | 1528 |
|
|
2022
Q1 | $2.09M | Buy |
219,700
+55,900
| +34% | +$647K | ﹤0.01% | 1483 |
|
|
2021
Q4 | $3.11M | Hold |
163,800
| – | – | 0.01% | 1164 |
|
|
2021
Q3 | $5.45M | Sell |
163,800
-9,700
| -6% | -$300K | 0.01% | 1010 |
|
|
2021
Q2 | $6.73M | Buy |
173,500
+2,800
| +2% | +$110K | 0.01% | 954 |
|
|
2021
Q1 | $8.23M | Buy |
170,700
+8,200
| +5% | +$394K | 0.02% | 836 |
|
|
2020
Q4 | $8.45M | Sell |
162,500
-4,900
| -3% | -$166K | 0.02% | 754 |
|
|
2020
Q3 | $4.48M | Buy |
167,400
+9,000
| +6% | +$207K | 0.01% | 973 |
|
|
2020
Q2 | $3.09M | Buy |
158,400
+25,500
| +19% | +$411K | 0.01% | 1025 |
|
|
2020
Q1 | $1.31M | Buy |
132,900
+15,000
| +13% | +$189K | ﹤0.01% | 1151 |
|
|
2019
Q4 | $1.31M | Hold |
117,900
| – | – | ﹤0.01% | 1191 |
|
|
2019
Q3 | $662K | Buy |
117,900
+32,100
| +37% | +$224K | ﹤0.01% | 1244 |
|
|
2019
Q2 | $742K | Buy |
85,800
+1,900
| +2% | +$14.4K | ﹤0.01% | 1217 |
|
|
2019
Q1 | $675K | Buy |
83,900
+19,100
| +29% | +$103K | ﹤0.01% | 1260 |
|
|
2018
Q4 | $266K | Buy |
64,800
+4,500
| +7% | +$22.4K | ﹤0.01% | 1431 |
|
|
2018
Q3 | $338K | Hold |
60,300
| – | – | ﹤0.01% | 1455 |
|
|
2018
Q2 | $793K | Buy |
60,300
+19,300
| +47% | +$265K | ﹤0.01% | 1249 |
|
|
2018
Q1 | $582K | Hold |
41,000
| – | – | ﹤0.01% | 1263 |
|
|
2017
Q4 | $336K | Hold |
41,000
| – | – | ﹤0.01% | 1345 |
|
|
2017
Q3 | $486K | Hold |
41,000
| – | – | ﹤0.01% | 1301 |
|
|
2017
Q2 | $412K | Buy |
+41,000
| New | +$459K | ﹤0.01% | 1326 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
State of Wisconsin Investment Board's TGTX Position: Q1 2026 in Review
State of Wisconsin Investment Board increased its TG Therapeutics (TGTX) stake by 78% in Q1 2026, buying an estimated $2.07M and bringing the position to 158,505 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #964.
State of Wisconsin Investment Board first reported a position in TGTX in Q2 2017 and has held it in 36 quarters since. The position peaked at $8.45M in Q4 2020. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- State of Wisconsin Investment Board held 158,505 shares of TG Therapeutics worth $5.27M as of Q1 2026.
- State of Wisconsin Investment Board bought 69,428 TG Therapeutics shares in Q1 2026, an estimated $2.07M.
- TG Therapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #964 holding.
- State of Wisconsin Investment Board first reported a position in TG Therapeutics in Q2 2017 and has held it in 36 quarters since.
- State of Wisconsin Investment Board's TG Therapeutics position peaked at $8.45M in Q4 2020.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.